NKX2-5 regulates human cardiomyogenesis via a HEY2 dependent transcriptional network-Reference-Cited by-同舟云学术

NKX2-5 regulates human cardiomyogenesis via a HEY2 dependent transcriptional network

Published:2018-04-10 Issue:1 Volume:9 Page:
ISSN:2041-1723
Container-title:Nature Communications
language:en
Short-container-title:Nat Commun

Author:

Anderson David J.,Kaplan David I.,Bell Katrina M.,Koutsis Katerina,Haynes John M.,Mills Richard J.,Phelan Dean G.,Qian Elizabeth L.,Leitoguinho Ana Rita,Arasaratnam Deevina,Labonne Tanya,Ng Elizabeth S.,Davis Richard P.,Casini Simona,Passier Robert,Hudson James E.,Porrello Enzo R.,Costa Mauro W.,Rafii Arash,Curl Clare L.,Delbridge Lea M.,Harvey Richard P.,Oshlack Alicia^ORCID,Cheung Michael M.,Mummery Christine L.,Petrou Stephen,Elefanty Andrew G.,Stanley Edouard G.,Elliott David A.^ORCID

Publisher

Springer Science and Business Media LLC

Subject

General Physics and Astronomy,General Biochemistry, Genetics and Molecular Biology,General Chemistry

Link

http://www.nature.com/articles/s41467-018-03714-x.pdf

Reference70 articles.

1. Kathiriya, I. S., Nora, E. P. & Bruneau, B. G. Investigating the transcriptional control of cardiovascular development. Circ. Res. 116, 700–714 (2015).

2. Davidson, E. H. & Erwin, D. H. Gene regulatory networks and the evolution of animal body plans. Science 311, 796–800 (2006).

3. Garg, V. et al. GATA4 mutations cause human congenital heart defects and reveal an interaction with TBX5. Nature 424, 443–447 (2003).

4. Li, Q. Y. et al. Holt-Oram syndrome is caused by mutations in TBX5, a member of the Brachyury (T) gene family. Nat. Genet 15, 21–29 (1997).

5. Schott, J. J. et al. Congenital heart disease caused by mutations in the transcription factor NKX2-5. Science 281, 108–111 (1998).

Cited by 85 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. The essential role of MED27 in stabilizing the mediator complex for cardiac development and function;Life Sciences;2024-11

2. RYR2 deficient human model identifies calcium handling and metabolic dysfunction impacting pharmacological responses;Frontiers in Cardiovascular Medicine;2024-07-08

3. Transient stabilization of human cardiovascular progenitor cells from human pluripotent stem cells in vitro reflects stage-specific heart development in vivo;Cardiovascular Research;2024-06-05

4. Current advances in human-induced pluripotent stem cell-based models and therapeutic approaches for congenital heart disease;Molecular and Cellular Biochemistry;2024-04-18

5. Pluripotent stem cells for target organ developmental toxicity testing;Toxicological Sciences;2024-03-28